Exane Derivatives’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $299 | Hold |
|
|||||
|
2022
Q1 | $335 | Hold |
|
|||||
|
2021
Q4 | $450 | Hold |
|
|||||
|
2021
Q3 | $740 | Hold |
|
|||||
|
2021
Q2 | $876 | Hold |
|
|||||
|
2021
Q1 | $1.17K | Hold |
|
|||||
|
2020
Q4 | $797 | Hold |
|
|||||
|
2020
Q3 | $968 | Hold |
|
|||||
|
2020
Q2 | $1.12K | Hold |
|
|||||
|
2020
Q1 | $1.06K | Sell |
|
|||||
|
2019
Q4 | $19.8K | Hold |
|
|||||
|
2019
Q3 | $8.25K | Hold |
|
|||||
|
2019
Q2 | $31.2K | Hold |
|
|||||
|
2019
Q1 | $52.1K | Hold |
|
|||||
|
2018
Q4 | $37.7K | Hold |
|
|||||
|
2018
Q3 | $61.7K | Hold |
|
|||||
|
2018
Q2 | $95.4K | Buy |
|